9th Annual Biomarkers Congress

Stem Cells: Harvard University

Total Score People Score Events Score
269 193 76
Date Event Presentation Speakers
May 6, 2014 Europe Drug Discovery Summit Europe Drug Discovery Summit Soumya S Ray
February 2, 2014 Stem Cells and Cancer (J8) Cancer Cell of Origin Registered attendees can view abstracts starting on 01/02/2014 Leonard I. Zon
Emerging Cancer Drug Targets in Development Pathways Bradley E Bernstein
February 2, 2014 Developmental Pathways and Cancer: Wnt, Notch and Hedgehog (J7) Cancer Cell of Origin Registered attendees can view abstracts starting on 01/02/2014 Leonard I. Zon
November 21, 2013 Cell Symposia: Using Stem Cells to Model and Treat Human Disease Modeling Genetic Blood Disease with iPS Cells George Daley
Using stem cells to dissect the population architecture of complex neurological disease: a case study in ALS Kevin Eggan
Genome editing to generate human cellular disease models Chad Cowan
Using stem cells to discover pathways that regulate repair and malignancy in skeletal muscle Session V – Stem cells in clinical trials Amy J. Wagers
Finding suppressors of disease-associated phenotypes using a cross-species comparison of tissue production from stem cells Leonard I. Zon
Panel on Overcoming Barriers for Translation of Stem Cell research Leonard I. Zon
November 14, 2013 2013 PQG Conference - Emerging Quantitative Issues in Disease Epigenetics Genome in 3D Leonid Mirny
September 15, 2013 ISSCR Regional Forum - Stem Cells in Translation Tissue Homeostasis Frank McKeon
Refreshment Break George Daley
May 31, 2013 ASCO Annual Meeting 2013 Optimizing the Role of Advanced Practice Professionals in Oncology Practice Lawrence N. Shulman
Hot Pathways for Targeted Therapy of B-Cell Malignancies James E. Bradner
Beyond Trastuzumab and Lapatinib: New Options for HER2-Positive Breast Cancer Ian E. Krop
Clinical Management, Molecular Alterations, and Future Perspectives in Urothelial Cancer David Kwiatkowski
Cancer Stem Cells: A New and Better Target in Pediatric Oncology? Scott A. Armstrong, George Daley
Reaping the Rewards of the Cancer Genome Atlas Project Levi A Garraway
Improving Cancer Care through Health Information Technology: Ethics and Practicality Lawrence N. Shulman
Education Sessions Robert G Maki, Stephen T Sonis
Education Sessions Deborah Schrag
Education Sessions Tracy T Batchelor
Education Sessions Michael B. Atkins, Jennifer A. Ligibel
Educations Sessions Monica M. Bertagnolli
Education Sessions Bruce E. Johnson, Elizabeth R. Gerstner
April 6, 2013 AACR Annual Meetings EPIGENETIC TARGETS FOR CANCER Anjana Rao, James E. Bradner
Developmental Origins of Cancer Chairperson: Richard J. Gilbertson, St. Jude Children's Research Hospital, Memphis, TN Stuart H. Orkin
Blood-Based Molecular Analysis of Cancer Daniel A Haber
Intrinsic and Microenvironment-Dependent Adaptive Responses that Regulate Drug Resistance Chairperson: Joan S. Brugge, Harvard Medical School, Boston, MA Joan S Brugge
The Interface Between Development and Cancer Using Model Organisms Chairperson: Michael M. Shen, Columbia University, New York, NY Leonard I. Zon
Emerging Single Cell Technologies in Cancer Research Chairperson: Garry P. Nolan, Stanford University School of Medicine, Stanford, CA Claude Lechene
Mutations in Epigenetic Regulators in Cancer Chairperson: Scott A. Armstrong, Memorial Sloan-Kettering Cancer Center, New York, NY Scott A. Armstrong
Mitotic Checkpoints Driving Cancer Therapeutic Strategies Chairperson: Peter K. Jackson, Genentech, Inc., South San Francisco, CA Timothy J Mitchison
Translational Control and Stress Response Pathways in Cancer Chairperson: Davide Ruggero, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA Karen Cichowski
Developmental and Molecular Origins of Brain Tumors Co-Chairpersons: Suzanne J. Baker, St. Jude Children's Research Hospital, Memphis, TN, and Cameron W. Brennan, Memorial Sloan-Kettering Cancer Center, New York, NY Cameron W Brennan
Synthetic Lethality and Genetic Approaches to Cancer Chairperson: Stephen J. Elledge, Harvard Medical School, Boston, MA Stephen J Elledge
Structural Aberrations in a Thousand Tumors Chairperson: Raju Kucherlapati, Harvard Medical School, Boston, MA Raju Kucherlapati
The Stanley J. Korsmeyer Memorial Symposium: Targeting Cell Death Pathways for Cancer Therapy Chairperson: Anthony G. Letai, Dana-Farber Cancer Institute, Boston, MA Anthony G. Letai
The Origins and Clinical Implications of Precancerous Lesions Chairperson: Cory Abate-Shen, Columbia University Irving Comprehensive Cancer Center, New York, NY Kornelia Polyak
Noncoding RNAs and Cancer Chairperson: Phillip A. Sharp, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA Jeannie T. Lee
New Cancer Vaccines Chairperson: Glenn Dranoff, Dana-Farber Cancer Institute, Boston, MA Glenn Dranoff
The Origins and Neoplastic Progression of Barrett's Esophagus Co-Chairpersons: Timothy C. Wang, Columbia University Medical Center, New York, NY, and Brian J. Reid, Fred Hutchinson Cancer Research Center, Seattle, WA Frank McKeon
Molecular Basis and Therapeutic Targeting of Bone Metastasis Co-Chairpersons: Yibin Kang, Princeton University, Princeton, NJ, and Matthew R. Smith, Massachusetts General Hospital Cancer Center, Boston, MA Matthew Smith
Molecular and Cellular Determinants of Brain Metastasis Co-Chairpersons: William C. Hahn, Dana-Farber Cancer Institute, Boston, MA, and Joan Massagué, Memorial Sloan-Kettering Cancer Center, New York, NY Rakesh K Jain, William C Hahn
Avatar: Individualized Human Cancer Models in Mice Kwok-Kin Wong
Next-Generation Therapeutic Modeling in Mice Pier Paolo
The Utility of Cancer Cell Line Screens for Modeling Drug Sensitivities Moderator: Jeffrey Settleman, Genentech, Inc., South San Francisco, CA Levi A Garraway
Clinical Trials Based on Mutations versus Histology William R Sellers, Lewis C Cantley
Human Papillomavirus: Beyond Cervical Cancer Chairperson: Maura L. Gillison, The Ohio State University Comprehensive Cancer Center, Columbus, OH Peter M Howley
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 1: Targeting Mechanisms of Therapeutic Resistance Chairperson: Matt V. Lorenzi, Janssen Research & Development, Spring House, PA Kwok-Kin Wong
Credentialing Response Biomarkers for Signal Transduction Inhibitors Chairperson: Neal Rosen, Memorial Sloan-Kettering Cancer Center, New York, NY Anthony G. Letai
Therapeutic Nanotechnology Chairperson: Gregory Lanza, Washington University, St. Louis, MO Omid C Farokhzad
Rational Combination Therapies in Cancer Chairperson: Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX Scott A. Armstrong
The Next Frontier in Targeted Therapy for Melanoma Chairperson to be announced Lynda Chin
New Paradigms in Molecular Pharmacology Chairperson: Angela N. Koehler, Broad Institute of MIT and Harvard, Cambridge, MA James E. Bradner
Metabolism and Signaling in Cancer Chairperson: Eyal Gottlieb, The Beatson Institute for Cancer Research, Glasgow, United Kingdom Nika N. Danial
Immune Modulation in the Tumor Microenviroment Chairperson: James P. Allison, Memorial Sloan-Kettering Cancer Center, New York, NY Raghu Kalluri
Cancer Imaging in Mice and Men Andrew L. Kung, Dana-Farber Cancer Institute, Boston, MA Andrew Kung
2-Oxoglutarate-Dependent Dioxygenases as Targets of Cancer-Causing Mutations and Cancer Therapeutics William G. Kaelin, Jr., Dana-Farber Cancer Institute, Boston, MA William G Kaelin
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY Xandra O Breakefield
Autocrine Activation of MET and Strategies to Overcome Adaptation for the Targeted Therapy of Acute Myeloid Leukemia A. Thomas Look, Dana-Farber Cancer Institute, Boston, MA Thomas A. Look
Stapled Peptides as Next-Generation Therapeutics Gregory L. Verdine, Harvard University, Cambridge, MA Gregory L Verdine
Prognostic and Predictive Biomarkers of Triple-Negative Breast Cancer Andrea L. Richardson, Brigham and Women's Hospital, Boston, MA Andrea L Richardson
Cancer Omics Beyond the Genome Sunney Xie
16th Annual Grant Writing Workshop Building Presence and Leadership through Empowered Communication Co-Chairpersons: Martine J. Piccart, Institut Jules Bordet, Brussels, Belgium, and Victoria M. Richon. Epizyme, Inc., Wellesley Hills, MA Kornelia Polyak
Patient-Derived Xenograft Models of Cancer: Where Are We Going? Chairperson: Matthew J. Ellis, Washington University Siteman Cancer Center, St. Louis, MO Tan Ince
WICR Career Mentoring Session Joan S Brugge
March 19, 2013 Stem Cells for Drug Developers Keynote Efficient Generation of Potent Vasculogenic Cells Rakesh K Jain
February 10, 2013 7thANNUAL DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCE: An Intensive Course on Translating Research into Drugs Drug Discovery Services for Preclinical Drug Discovery: Centers & CROs Marcie Glicksman
Session Overview Marcie Glicksman
February 3, 2013 New Frontiers in Neurodegenerative Disease Research (J8) Genome Integrity, Chromatin Remodeling and Neurodegenerative Disorders Li Huei Tsai
iPSC Modeling of Developmental and Degenerative Neurological Diseases (Joint) Li Huei Tsai
January 20, 2013 Tumor Invasion and Metastasis GEM models in translational research Lynda Chin
Regulation of metastasis via tumor-stromal interactions Randolph S Watnick
Session 8: Treatment of Metastatic Cancer Bruce R. Zetter
July 23, 2012 Neurotrauma 2012 Contrasting Pathological Pathways in Traumatic, Ischemic and Hemorragic Brain Injuries Eng H. Lo
April 1, 2012 Regenerative Tissue Engineering and Transplantation (Z3) Cells and Biological Mechanisms I Kevin Eggan
New Vistas in Tissue Regeneration and Engineering (Joint) Kenneth R Chien
February 9, 2012 Dermatogenetics Roles for MITF in melanomagenesi David E Fisher
October 3, 2011 2011 World Stem Cell Summit Plenary Discussion | State of the States: Research Programs, Public Funds and Interstate Collaborations Melissa J. Lopes
The Emergence of Academic Interdisciplinary Stem Cell Institutes as Engines for Translational Progress Brock Reeve
September 11, 2011 Stem Cells in Development and Disease Stem Cells in Development and Disease Stuart Orkin, Konrad Hochedlinger, Leonard I. Zon, George Daley
August 20, 2011 20th Annual Short Course on Experimental Models of Human Cancer Tumor Angiogenesis And Microenvironment Rakesh K Jain
Modeling the Ras Pathway in Cancer Karen Cichowski
Zebrafish Models to Dissect Human Cancer Pathways Thomas A. Look
EGFR Pathways and Cancer Pasi A Janne
Personalized medicine Raju Kucherlapati
August 14, 2011 Gastrointestinal Tract XIV: Stem Cells, Adaptation, Inflammation and Cancer Gut Leukocyte Homing Jorge Rodrigo Mora
Autophagy in the Mucosa Ramnik J. Xavier
May 26, 2011 Idibell Cancer Conference on Metastasis and Angiogenesis Tumor microenvironment controls the rate of metastasis Raghu Kalluri
March 6, 2011 Stem Cells, Cancer and Metastasis (C4) Genes that Regulate Migration and Invasion Joan S Brugge
Molecular characterization of circulating tumor cells Daniel A Haber
Stem Cells in Normal Lung and Lung Cancer Carla Bender Kim
Roundtable: Cancer Stem Cells in Metastasis: Insights and Controversies Daniel A Haber
March 3, 2011 Stem Cells, Development, and Cancer Dissecting the mechanisms of cellular reprogramming Konrad Hochedlinger
Reversible tolerance to anticancer drugs Jeffrey Settleman
February 17, 2011 15th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma Primary Central Nervous System Lymphoma Tracy T Batchelor
Management of Autoimmune Issues in Chronic Lymphocytic Leukemia Jennifer R. Brown
Comment Jennifer R. Brown
CDK Inhibitors Noopur Raje
PI3K | Akt Pathway Inhibitors Jennifer R. Brown
BCR | Downstream Therapeutic Targets Jennifer R. Brown
Aggressive Lymphoid Malignancies (Acute Lymphoblastic Leukemia, Lymphoblastic Leukemia, Burkitt Lymphoma) Daniel J. DeAngelo
Outlook for Management of Bone Disease in Multiple Myeloma Noopur Raje
Multiple Myeloma Noopur Raje
Acute Myeloid Leukemia | Myelodysplastic Syndromes Daniel J. DeAngelo
January 12, 2011 Type 2 Diabetes, Insulin Resistance and Metabolic Dysfunction (J1) Genetic and Pharmacological Interventions to Treat Age-related Diseases | Columbine Ballroom David A Sinclair
Systems Analysis of Mitochondrial Function | Columbine Ballroom Vamsi K Mootha
Transcriptional Regulation of Adipogenesis and Energy Homeostasis | Columbine Ballroom Bruce Spiegelman
Insulin Resistance, Mitochondrial Dysfunction and Lipotoxicity in Humans | New and Novel Aspects of Insulin Signaling and Insulin Resistance C. Ronald Kahn
Panel: Mechanisms of Insulin Resistance: Recent Advances and Current Controversies (Joint) | Columbine Ballroom Barbara Kahn
January 12, 2011 Obesity (J2) Genetic and Pharmacological Interventions to Treat Age-related Diseases | Columbine Ballroom David A Sinclair
Systems Analysis of Mitochondrial Function | Columbine Ballroom Vamsi K Mootha
Transcriptional Regulation of Adipogenesis and Energy Homeostasis | Columbine Ballroom Bruce Spiegelman
Diabetes (J1) | New and Novel Aspects of Insulin Signaling and Insulin Resistance C. Ronald Kahn
December 8, 2010 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium DNA Repair | Ballroom C-3 Daniel P. Silver
DNA repair and breast cancer: Therapeutic opportunities and challenges Daniel P. Silver
Measuring and modeling cell death pathways in tumor cells Peter K. Sorger
Panel Discussion Judy E Garber
Clinical Science Forum - Controversies in Screening for Breast Cancer | Ballroom A Eric P. Winer
The role of providers in breast cancer disparities Nancy L. Keating
October 27, 2010 Colorectal Cancer: Biology to Therapy Molecular imaging approaches to colorectal cancer Umar Mahmood
October 21, 2010 21st Century Treatment of Heart Failure Imaging Robert A. Levine
September 12, 2010 Joint Metastasis Research Society-AACR Conference in Conjunction with the Tumor Microenvironment Working Group of the AACR Seed and soil hypothesis revisited Rakesh K Jain
Keynote Address | Title to be announced Joan Brugge
Welcome Bruce R. Zetter
July 11, 2010 3rd International Congress On Stem Cells And Tissue Formation Biomaterials for Cell Transplantation and Drug Delivery | Amy Brock Amy Brock
Programming Cells In Vivo Using Polymers David J. Mooney
June 26, 2010 American Society for Investigative Pathology 2010 Summer Academy Mechanisms of Leukocyte-Mediated Tissue Injury (Focus on Immunopathology) Andrew Lichtman
Leukocyte Activation (Cellular Activation in the Innate and Adaptive Immune Systems) Andrew Lichtman
Resolution of Inflammation Bruce D. Levy
Inflammasomes and Inflammation Kenneth Rock
Athersclerosis: Inflammation and Wound Healing in the Vessel Wall Richard N. Mitchell
June 14, 2010 Development and Stem Cells in the Pancreas Insulin Signaling and the Pathogenesis of Diabetes C. Ronald Kahn
May 19, 2010 Towards Personalized Cancer Medicine New Cancer Targets Emerging From Studies of the von Hippel-Lindau Tumor Suppressor Protein William G Kaelin
Functionalizing the Cancer Genome Lynda Chin
SESSION III: Oncogenomics and Tumor Profiling Lynda Chin
Target and Drug Discovery in Oncology: The Right Drug for the Right Patient D. Gary Gilliland
PANEL DISCUSSION Lynda Chin
May 12, 2010 Stem Cells, Tissue Homeostasis and Cancer Keynote Lecture Stuart Orkin
February 1, 2010 4th DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCE Session Overview Marcie Glicksman
II. In-vitro Testing: Early Phases of Drug Discovery Marcie Glicksman
Stem Cells to Accelerate Drug Discovery for Neurodegenerative Disease Lee Rubin
Developing Relevant High-Throughput Assays for the Identification of Potential Drug Candidates Marcie Glicksman
Track 1: Target Validation to Lead Optimization AD Case Study Marcie Glicksman
January 22, 2010 2010 Gastrointestinal Cancers Symposium General Session IV: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract: Prevention, Screening, and Diagnosis Sapna Syngal
Normalizing the Tumor Microenvironment to Improve Drug Delivery and Efficacy Rakesh K Jain
Newer Radiation Techniques in the Treatment of Hepatobiliary and Pancreatic Cancers Harvey J. Mamon
Advanced Imaging Techniques Dushyant Sahani
Gastroenterologist William R. Brugge
Advanced Imaging Techniques Dushyant Sahani
November 19, 2009 Stem Cells 2009 Regulation of micoRNA biogenesis in stem cells and cancer Richard Gregory
October 1, 2009 6TH ANNUAL MEETING OF THE INTERNATIONAL SOCIETY OF GASTROINTESTINAL ONCOLOGY (ISGIO) Case Presentation 1: Stage II David Ryan
August 5, 2009 New Frontiers in Cancer Drug Development A New Paradigm for Translational Cancer Research: Targeting Endocrine Factors and Real Human Tumors Sandra S. McAllister
Turning Cancer Sequencing Data into Therapeutic Targets Heidi Greulich
Combinations of Novel and Conventional Cancer Agents: Challenges and Opportunities Kenneth C Anderson
The Use of Genetically Engineered Mouse Lung Cancer Models to Assess Effectiveness of Targeted Therapeutic Combinations Kwok-Kin Wong
The Evolving Treatment Paradigm in Multiple Myeloma Kenneth C Anderson
March 25, 2009 The Stem Cell Meeting '09 Agenda Panel: Translational Medicine – Recent Advances and Challenges Douglas A Melton
March 23, 2009 StemCONN: Connecticut's International Stem Cell Research Symposium Reprogramming of Adult Cells into Embryonic Stem Cells Konrad Hochedlinger
February 28, 2009 LIMB LENGTHENING AND RECONSTRUCTION SOCIETY: ASAMI–NORTH AMERICA Welcome, Opening Remarks James J McCarthy
Bar Excision and/or Plateau Elevation Perry Schoenecker
Gradual Deformity Correction James J McCarthy
February 28, 2009 PEDIATRIC ORTHOPAEDIC SOCIETY OF NORTH AMERICA Surgical Management in the OI Upper Extremity Donald Bae
Upper Extremity Trauma Peter Waters
Bar Excision and/or Plateau Elevation Perry Schoenecker
Gradual Deformity Correction James J McCarthy
January 25, 2009 "Emerging Themes in Tumor Suppressors: Function and Clinical Implications in the Post-Genomic Era (B1) p53 and ARF Pier Paolo
PTEN/FOXO/TSC/LKB Ronald A DePinho
Tissue Context and Tumor Suppressor Function Andrea I McClatchey
January 5, 2009 High Content Analysis Multi-Color Live Cell Immunofluorescence Timecourse Analysis of Human-Induced Pluripotent Stem Cell Formation Thorsten M Schlaeger
December 11, 2008 SAN ANTONIO BREAST CANCER SYMPOSIUM Breast cancer stem cells: in search of definitions, markers, and clinical relevance Kornelia Polyak
December 7, 2008 AMERICAN SOCIETY FOR MATRIX BIOLOGY 2008 Meeting SIG 1: Syndecan1 Shedding: An Innate Immune Response to Infection Pyong Woo Park
November 22, 2008 Collaborative Ependymoma Research Network (CERN) Integrated Genomic And Proteomic Analysis Identifies Distinct GBM Subclasses. Cameron W Brennan
September 29, 2008 Stem Cells, Cancer and Aging (S3) New Targets and Therapeutic Approaches to Cancer and Aging Gregory L Verdine
September 23, 2008 Integrative Data Analysis An Integrated Data Warehouse for Biomedical and Translational Research John Quackenbush
Analysis of Copy-Number Variants in Association Studies for Complex Traits Iuliana Ionita Laza
August 11, 2008 CELLutions SUMMIT Programming Cells in Situ David Mooney
Developing Stem Cell-Based Therapies for Cancer Khalid Shah
June 11, 2008 6th ISSCR Annual Meeting Plenary I: Presidential Symposium on Developmental Biology George Daley
DIRECT REPROGRAMMING TO MAKE PANCREATIC β CELLS Douglas Melton
Standards and Methodology of iPS Cells Panel Discussion George Daley
GENOMEWIDE STUDIES OF THE PLURIPOTENT CHROMATIN STATE Brad Bernstein
June 11, 2008 Internation Society for Stem Cell Research International Society Society For Stem Cell Reasearch Brad Bernstein, Douglas A Melton, Carla Bender Kim
May 30, 2008 ASCO Annual'08 Meeting breast cancer-- Adjuvant Chemotherapy of Breast Cancer: Do We Still Need Anthracyclines? Eric P. Winer
breast cancer-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
breast cancer-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
cancer genetics-- Molecular Pathways of Cancer Predisposition in Children, Adolescents, and Young Adults Lisa Diller
cancer genetics-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
cancer genetics-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
cancer prevention/epidemiology-- Molecular Pathways of Cancer Predisposition in Children, Adolescents, and Young Adults Lisa Diller
cancer prevention/epidemiology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
cancer prevention/epidemiology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
central nervous system tumors-- Managing the Medical Complications of Patients with Brain Tumors (CPO10A) Patrick Y. Wen
central nervous system tumors-- Managing the Medical Complications of Patients with Brain Tumors (CPO10B) Patrick Y. Wen
clinical trials-- Early Data: Presenting and Publishing Preliminary Results Donna S. Neuberg
ethics-- Early Data: Presenting and Publishing Preliminary Results Donna S. Neuberg
gastrointestinal (noncolorectal) cancer-- Gastrointestinal Stromal Tumor (GIST) Comes of Age: Current Management Using Molecular Pathology, Surgery, and Targeted Therapy George Daniel Demetri
geriatric oncology--Adjuvant Chemotherapy of Breast Cancer: Do We Still Need Anthracyclines? Eric P. Winer
lung cancer-- Targeted and Novel Agents in Small Cell Lung Cancer Bruce E. Johnson
melanoma/skin cancers-- Melanoma in Children, Adolescents, and Young Adults David E Fisher
patient and survivor care-- Managing the Medical Complications of Patients with Brain Tumors (CPO10A) Patrick Y. Wen
patient and survivor care-- New Models for Survivorship Care Programs (M15) Lawrence N. Shulman
patient and survivor care-- Treatment Approaches and Functional Outcomes in Pediatric Sarcomas Mark Gebhardt
patient and survivor care-- Managing the Medical Complications of Patients with Brain Tumors (CPO10B) Patrick Y. Wen
pediatric cancer-- Molecular Pathways of Cancer Predisposition in Children, Adolescents, and Young Adults Lisa Diller
pediatric cancer-- Challenges and Optimizing Outcomes in Adolescents and Young Adults with Cancer Karen H. Albritton
pediatric cancer-- Treatment Approaches and Functional Outcomes in Pediatric Sarcomas Mark Gebhardt
pediatric cancer-- Melanoma in Children, Adolescents, and Young Adults David E Fisher
sarcoma/bone and soft tissue cancers-- Predicting and Targeting Drug Resistance to Tyrosine Kinase Inhibitors Jeffrey Adam Engelman
sarcoma/bone and soft tissue cancers-- Treatment Approaches and Functional Outcomes in Pediatric Sarcomas Mark Gebhardt
tumor biology-- Predicting and Targeting Drug Resistance to Tyrosine Kinase Inhibitors Jeffrey Adam Engelman
meet the professor sessions-- New Models for Survivorship Care Programs (M15) Lawrence N. Shulman
clinical problems in oncology-- Managing the Medical Complications of Patients with Brain Tumors (CPO10A) Patrick Y. Wen
clinical problems in oncology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
clinical problems in oncology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
clinical problems in oncology-- Managing the Medical Complications of Patients with Brain Tumors (CPO10B) Patrick Y. Wen
April 6, 2008 Islet and Beta Cell Development and Transplantation Stem Cells and Optimization of Beta Cell Function to Transplantation (Joint) Douglas Melton
Understanding and Controlling Autoimmunity Arlene H. Sharpe
Stem Cells and Pancreatic Islets Douglas Melton
Islet Proliferation and Survival Sonya G. Fonseca
March 30, 2008 Inflammation, Microenvironment and Cancer Fibroblasts and Stem Cells Kornelia Polyak
March 25, 2008 PATHWAY ANALYSIS Chairperson’s Remarks Tara M Love
Not miR-ly Small RNAs: Genetic Approach to Defining microRNA Pathways Tara M Love
March 25, 2008 CANCER MOLECULAR MARKERS Therapeutic Potential of Targeting microRNAs in Chronic Myeloid Leukemia Tara M Love
Chairperson’s Remarks Tara M Love
March 24, 2008 Signaling Pathways in Cancer and Development Adult Stem Cells Leonard I. Zon
Organogenesis and Cancer Frank McKeon
Enabling Technologies and Treatment David T Scadden
Hedgehog Signaling in Development and Cancer Norbert Perrimon
Stem Cell Renewal Mechanisms Konrad Hochedlinger
March 16, 2008 Advances in Cancer Research: From the Laboratory to the Clinic Title to be announced William G Kaelin
Clinical Targeting and Inhibition of Tyrosine Kinases in GIST and Sarcomas: Lessons for Cancer Therapy and Future Directions George Daniel Demetri
RNAi, NON-CODING RNA, AND microRNA William C Hahn
Functional Genomics, Experimental Models, and Cancer William C Hahn
March 9, 2008 DNA DAMAGE, MUTATION & CANCER IgH Class Switching, DNA End-Joining, Translocation, and Cancer Frederick Alt
February 24, 2008 Tumor Suppressors and Stem Cell Biology Tumor Suppressors and the Evolution of Stem Cells Andrea I McClatchey
Tumor Suppressors and the Environmental Control of Stem Cells David T Scadden
Stem Cell Self-Renewal Stuart H. Orkin
February 12, 2008 AACR - The Role of Cancer Stem Cells in the Initiation and Propagation of Tumorigenesis Regulation of Stem Cell Quiescence and Longevity in Normal and Malignant Hematopoiesis D. Gary Gilliland
Regulation of Stem Cells Stuart H. Orkin
January 22, 2008 Ubiquitin and Cancer: From Molecular Targets and Mechanisms to the Clinic SESSION 1: ONCOGENIC SIGNALING I Alfred L. Goldberg
SESSION 5: CLINICAL AND PRECLINICAL STUDIES TARGETING THE UPS I Kenneth C Anderson
New Insights into Proteasome Function Alfred L. Goldberg
Proteasome Inhibition for the Treatment of Hematological Malignancies Kenneth C Anderson
Proteasome Inhibition to Treat Solid Malignancies James C. Cusack
January 18, 2008 Translational Research Program Stem Cell Symposium Circulating Endothelial Cells Dan G Duda
January 15, 2008 Molecular, Cellular, Physiological, and Pathogenic Responses to Hypoxia Keynote Session (Joint) M. Judah Folkman
Workshop 1: Experimental Models of Angiogenesis Jing Chen
Cancer William G Kaelin
Pathological Angiogenesis Christiana DelloRusso
Novel Therapeutic Targets in Angiogenesis Zolt P. Arany
January 13, 2008 Pathological and Physiological Regulation of Cardiac Hypertrophy Modifiers of Heart Disease Christine Seidman
Stem Cells and Gene Therapy: The Ongoing Debate Yuh-Shin Chang
December 13, 2007 Stem Cells 2007 TBC David T Scadden
December 5, 2007 Sixth Annual International Conference on Frontiers in Cancer Prevention Research PLENARY SESSION I - PREDICTING CANCER RISK: ADVANCES IN GENETICS, BIOMARKERS, AND BEHAVIORAL SCIENCE Kenneth Offit
December 1, 2007 47TH American Socieity of Cell Biology Design Principles for Connecting the Genome to the World I Philips, C. Ajo-Franklin
Minisymposium 1A:Cell Biology Working Group: Challenges in Cell Biology—The Nature of Cytoplasm Timothy J Mitchison
Interphase and Mitotic CDKs Follow Kinetically Distinct Paths to Activation in Human Cells. C. Zhang
*Single-Molecule Analysis Reveals the Distribution of Potential vs. Active DNA Replication Origins in Human Cells R. Lebofsky
Cell Matrix Interactions (Room 140A) Yu-Li Wang
Advances in Bone Cell Molecular Biology: Epigenetic Control Jane Lian, Gary S Stein
CLASPs Clutching Microtubule Networks (Room 209 B/C) David Van Vactor
At the Limits: Optical Methods for Single Molecules, Cells, and Organisms Jennifer Waters, Samara Rech-Peterson
High Performance Image Analysis and Photomanipulative Techniques for Jeffrey Nickerson
Building the Cell (Room 140B) L Mahadevan
Systems Biology of Receptor Tyrosine Kinase Networks (Room 206) Peter K. Sorger
Public Service Award Presentation Matthew Michael
Primary Role for Centrosome Proteins in Cilia Formation and Cilia-associated Disorders B Delaval, L Covassin Barberis, N Lawson, Stephen J Doxsey
Cell-Type Variation in Responses to Anti-mitotic Drugs. C Loy, J Orth, C Shamu, M Tsui, V Yanamadala, Timothy J Mitchison
Fluorescence Correlation Spectroscopy Workshop Daniel Needham
Actin Disassembly by Whole-Filament Destabilization.v H Kueh, W M Brieher, Timothy J Mitchison
How Does Thrombospondin Induce CNS Synaptogenesis? J. T. Lawler
Identifying Matrix- and Growth Factor-induced Transcriptional Dichotomies by Stochastic Sampling. K A Janes, Joan Brugge
High-Tech Cell Biology Kendall Knight
DNA Damage Signaling Events Revealed by 4Pi Microscopy. Kendall Knight, Brian T Bennett
Novel Microscopy Methodology to Examine DNA Damage Signaling and Repair. Brian T Bennett
Heterochromatin Formation in Fission Yeast. M Huarte, Yang Shi
Anti-fi brotic Property of CTGF siRNA in the Liver via Targeted Delivery to Hepatic Stellate Cells. David Roger Brigstock, C Lawrencia
Mallory Body Formation in the Livers of Drug-primed Mice Is Regulated by an Epigenetic Mechanism Jian Li
Myosin-activated Random Stress Fluctuations in the Actin Cytoskeleton David Weitz
Cytoplasmic Dynein Is a Better Navigator than Kinesin on Tau-decorated Microtubules. J. L. Ross
Determining the Molecular Architectures of Cellular Machines by Satisfaction of Spatial Restraints: The Nuclear Pore Complex. Adrian Salic
Posters Displayed:Monday Joan Brugge
Amaxa GmbH: Alan D Andrea
Post-Cytokinetic DNA Segregation by ATPases That Form DNA-Conducting Channels Tom A Rapoport, N L Sullivan, K Marquis
Maintenance of Polarity and Cell Shape in Vibrio cholerae Matthew K Waldor
Biochemical Characterization of Type III-secreted Bacterial Acetyltransferases J Orth
November 14, 2007 Advances in Breast Cancer Research Basic and Applied Issues in Colon Cancer Studied in the Min Mouse and Pirc Rat Kindreds Simon Dove
MURINE MODELS Simon Dove
Normalization of Tumor Vasculature and Microenvironment by Antiangiogenic Therapies: From the Bench to Bedside and Back Rakesh K Jain
The Role of Inflammation in Colorectal Adenoma Formation Ross Levine
Obesity, Energy-Balance, Related Hormones and Colon Cancer John Quackenbush
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 11: Anti-Infectious Drug Discovery & Development (II) (09:00-12:20) Irene Bosch
Session 11: Identification of Novel and Effective Antiviral Treatment and zstablishment of Disease Pathogenesis: A journey of Global Gene Expression of dengue virus infection (11:20-11:40) Irene Bosch
November 4, 2007 AACR Centennial Conference: Translational Cancer Medicine Plenary Session 2: Proteomics, Genomics and Biomarker Discovery Gregory L Verdine
Plenary Session 6: Clinical Intervention and Populations Outcomes: Global Strategies Rakesh K Jain
October 2, 2007 The Stem Cell Summit Welcome and meeting overview | Industry Overview David T Scadden
July 14, 2007 Skeletal Muscle Satellite & Stem Cells In Vivo Fluorescence Imaging of Muscle Regeneration By Transplanted EGFP-Labeled Myoblasts Yaming Wang
March 12, 2007 THE STEM CELL MEETING – Burrill and Compay Hunting the Heart Stem Cell: Implications for Cardiovascular Disease Kenneth R Chien
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.